| 3FDN: reference: Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity., Coumar MS, Leou JS, Shukla P, Wu JS, Dixit AK, Lin WH, Chang CY, Lien TW, Tan UK, Chen CH, Hsu JT, Chao YS, Wu SY, Hsieh HP, J Med Chem. 2009 Feb 26;52(4):1050-62. PMID: 19140666 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).